ResearcherNanjing General Hospital of Nanjing Military CommandNo recent work listed

Wu Ji

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6378-2431; OpenAlex author ID A5071751207. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 6

Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 1 paper

Papers 3

MiR-539 functions as a tumor suppressor in pancreatic cancer by targeting TWIST1. Co-author DOI 10.1016/j.yexmp.2019.04.012 ↗
Down-regulation of MiR-539 Indicates Poor Prognosis in Patients with Pancreatic Cancer. Last author DOI 10.1515/biol-2018-0059 ↗
The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic… Last author DOI 10.1016/j.biopha.2017.10.026 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bujian Pan · 2 shared papers, 2017–2019 · strength 0.17
- Paper MiR-539 functions as a tumor suppressor in pancreatic cancer by targeting TWIST1. DOI 10.1016/j.yexmp.2019.04.012 ↗
- Paper The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transitio… DOI 10.1016/j.biopha.2017.10.026 ↗
Haibo Yu · 2 shared papers, 2017–2019 · strength 0.17
- Paper MiR-539 functions as a tumor suppressor in pancreatic cancer by targeting TWIST1. DOI 10.1016/j.yexmp.2019.04.012 ↗
- Paper The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transitio… DOI 10.1016/j.biopha.2017.10.026 ↗
Haibo Yu · 1 shared paper, 2018 · strength 0.12
- Paper Down-regulation of MiR-539 Indicates Poor Prognosis in Patients with Pancreatic Cancer. DOI 10.1515/biol-2018-0059 ↗
Jing Cai · 1 shared paper, 2019 · strength 0.10
- Paper MiR-539 functions as a tumor suppressor in pancreatic cancer by targeting TWIST1. DOI 10.1016/j.yexmp.2019.04.012 ↗
Xizhou Lin · 1 shared paper, 2017 · strength 0.07
- Paper The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transitio… DOI 10.1016/j.biopha.2017.10.026 ↗
Jun Xiao · 1 shared paper, 2017 · strength 0.07
- Paper The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transitio… DOI 10.1016/j.biopha.2017.10.026 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.